Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hematologic Neoplasms × acalabrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 44 Lymphoma, Mantle-Cell 24 Lymphoma, Large B-Cell, Diffuse 13 Lymphoma, Non-Hodgkin 10 Lymphoma 7 Leukemia, B-Cell 6 Waldenstrom Macroglobulinemia 4 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia 3 Recurrence 2 Multiple Myeloma 2 Leukemia, Prolymphocytic 2 Squamous Cell Carcinoma of Head and Neck 1 Pyloric Stenosis, Hypertrophic 1 Part1: Advanced B-cell Malignancies 1 Ovarian Neoplasms 1 Neuritis 1 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Heart Failure 1 DLBCL 1 Chromosome 17 deletion 1

Interventions

Cyclophosphamide 75 fludarabine 65 fludarabine phosphate 40 Tacrolimus 39 Whole-Body Irradiation 37 Mycophenolic Acid 34 Busulfan 30 Melphalan 27 Antilymphocyte Serum 21 thymoglobulin 20 Methotrexate 20 Sirolimus 19 Thiotepa 18 Standard of Care 18 Rituximab 17 Azacitidine 17 venetoclax 16 Stem Cell Transplantation 16 Granulocyte Colony-Stimulating Factor 16 Practice Guidelines as Topic 15 Cytarabine 14 Filgrastim 13 Mesna 12 Bortezomib 12 Nivolumab 10 Peripheral Blood Stem Cell Transplantation 9 Dexamethasone 9 Blood Specimen Collection 9 trametinib 8 Specimen Handling 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05205252 2023-08-15

ARIA

Ipsen

Phase 1/2 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡